Chugai Pharmaceutic-Unsp ADRCHGCY
13F holders, Q3 2024 (September 30)8holders +2
2new positions
1sold out
$24.15avg. 13F price*
At the end of Q3 2024, 8 institutions reported holding Chugai Pharmaceutic-Unsp ADR (CHGCY) in their 13F filings, up 2 from Q2 2024. 2 opened new positions and 1 sold out. The largest holders were Sterling Capital Management LLC ($1.7M), Confluence Investment Management LLC ($926K) and Rhumbline Advisers ($716K).
- Company
- Chugai Pharmaceutic-Unsp ADR
- CUSIP
- 171269103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $261K |
| Exits | 1 | $4.1M |
All 13F filers, Q2 2024 → Q3 2024: 12,513 shares bought and 235,494 shares sold, net −222,981 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Sterling Capital Management LLC | 0.02% | — | 71,771 | $1.7M |
| Confluence Investment Management LLC | 0.01% | Reduce -2.9% | 38,457 | $926K |
| Rhumbline Advisers | 0.00% | Reduce -5.0% | 29,725 | $716K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -10.6% | 14,543 | $350K |
| Riverbridge Partners LLC | 0.00% | New | 9,781 | $236K |
| GAMMA Investing LLC | 0.02% | Add +29.2% | 7,414 | $179K |
| Brooklyn Investment Group | 0.01% | New | 1,042 | $25K |
| Richardson Financial Services Inc. | 0.00% | Add +100.0% | 28 | $586 |
"% of holder's portfolio" is CHGCY's weight in each manager's 13F, not the share of Chugai Pharmaceutic-Unsp ADR the manager owns.